MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Veeravalli, Krishna Kumar ^a   Chetty, Chandramu ^a   Ponnala, Shivani ^a   Gondi, Christopher S ^a   Lakka, Sajani S ^a   Fassett, Daniel ^a   Klopfenstein, Jeffrey D ^a   Dinh, Dzung H ^a   Gujrati, Meena ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA9BETA1 INTEGRIN; BETA INTEGRIN; CATHEPSIN B; GELATINASE B; INTEGRIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 6; VITRONECTIN RECEPTOR; INTEGRIN ALPHA9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE CONSTRUCT; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; TUMOR XENOGRAFT; WOUND HEALING; ANIMAL; CELL MOTION; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTICELLULAR SPHEROID; NUDE MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CATHEPSIN B; CELL ADHESION; CELL MOVEMENT; DOWN-REGULATION; FLOW CYTOMETRY; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA CHAINS; INTEGRIN ALPHA6BETA1; INTEGRIN ALPHAVBETA3; INTEGRINS; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPHEROIDS, CELLULAR; WOUND HEALING;

EID: 77955374803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011583     Document Type: Article

References (52)

1. Albelda SM, Buck CA (1990) Integrins and other cell adhesion molecules. FASEB J 4: 2868-2880.
2. Hemler ME (1990) VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 8: 365-400.
3. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
4. Ruoslahti E (1999) Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76: 1-20.
5. Schaller MD, Parsons JT (1994) Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 6: 705-710.
6. Shattil SJ, Brugge JS (1991) Protein tyrosine phosphorylation and the adhesive functions of platelets. Curr Opin Cell Biol 3: 869-879.
7. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
8. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22.
9. Giese A, Westphal M (1996) Glioma invasion in the central nervous system. Neurosurgery 39: 235-250.
10. Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
11. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523.
12. Grondahl-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, et al. (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 53: 2513-2521.
13. Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, et al. (1999) Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17: 555-566.
14. Raithatha SA, Muzik H, Muzik H, Rewcastle NB, Johnston RN, et al. (2000) Localization of gelatinase-A and gelatinase-B mrna and protein in human gliomas. Neuro-oncol 2: 145-150.
15. Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP, et al. (1998) Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol 13: 1153-1157.
16. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, et al. (1993) Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208-2211.
17. Goldbrunner RH, Bernstein JJ, Tonn JC (1998) ECM-mediated glioma cell invasion. Microsc Res Tech 43: 250-257.
18. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, et al. (1994) Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 54: 5016-5020.
19. Bass R, Werner F, Odintsova E, Sugiura T, Berditchevski F, et al. (2005) Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. J Biol Chem 280: 14811-14818.
20. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, et al. (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14: 55-63.
21. Rao NK, Shi GP, Chapman HA (1995) Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression. J Clin Invest 96: 465-474.
22. Berquin IM, Cao L, Fong D, Sloane BF (1995) Identification of two new exons and multiple transcription start points in the 59-untranslated region of the human cathepsin-B-encoding gene. Gene 159: 143-149.
23. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, et al. (1994) Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54: 6027-6031.
24. Dorsett Y, Tuschl T (2004) sirnas: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3: 318-329.
25. Novina CD, Sharp PA (2004) The rnai revolution. Nature 430: 161-164.
26. Crowe DL, Shuler CF (1999) Regulation of tumor cell invasion by extracellular matrix. Histol Histopathol 14: 665-671.
27. Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del VL, et al. (2008) Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol 10: 968-980.
28. Gingras MC, Roussel E, Bruner JM, Branch CD, Moser RP (1995) Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol 57: 143-153.
29. Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R, et al. (2003) Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol (Berl) 105: 49-57.
30. Gondi CS, Rao JS (2009) Therapeutic potential of sirna-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases. Methods Mol Biol 487: 267-281.
31. Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, et al. (2006) RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther 5: 3197-3208.
32. Lakka SS, Gondi CS, Rao JS (2005) Proteases and glioma angiogenesis. Brain Pathol 15: 327-341.
33. Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, et al. (2005) Specific interference of upar and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. J Biol Chem 280: 21882-21892.
34. Smith HW, Marshall CJ (2010) Regulation of cell signalling by upar. Nat Rev Mol Cell Biol 11: 23-36.
35. Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY (2002) Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277: 9749-9756.
36. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100: 9482-9487.
37. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3: 489-501.
38. Dehart GW, Jin T, mccloskey DE, Pegg AE, Sheppard D (2008) The alpha9beta1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel. Proc Natl Acad Sci U S A 105: 7188-7193.
39. Liu S, Slepak M, Ginsberg MH (2001) Binding of Paxillin to the alpha 9 Integrin Cytoplasmic Domain Inhibits Cell Spreading. J Biol Chem 276: 37086-37092.
40. Young BA, Taooka Y, Liu S, Askins KJ, Yokosaki Y, et al. (2001) The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillinindependent manner. Mol Biol Cell 12: 3214-3225.
41. Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, et al. (2004) Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689.
42. Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, et al. (2007) Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 282: 15187-15196.
43. Gupta SK, Vlahakis NE (2010) Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles. Cell Adh Migr 4: 1-5.
44. Gupta SK, Vlahakis NE (2009) Integrin alpha9beta1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase. J Cell Sci 122: 2043-2054.
45. Zachary I, Rozengurt E (1992) Focal adhesion kinase (p125fak): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 71: 891-894.
46. Aguirre-Ghiso JA (2002) Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21: 2513-2524.
47. Chaurasia P, guirre-Ghiso JA, Liang OD, Gardsvoll H, Ploug M, et al. (2006) A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J Biol Chem 281: 14852-14863.
48. Smith HW, Marra P, Marshall CJ (2008) upar promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. J Cell Biol 182: 777-790.
49. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, et al. (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro-oncol 7: 164-176.
50. Gondi CS, Dinh DH, Gujrati M, Rao JS (2008) Simultaneous downregulation of upar and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas. Int J Oncol 33: 783-790.
51. Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, et al. (1997) In vitro inhibition of human glioblastoma cell line invasiveness by antisense upa receptor. Oncogene 14: 1351-1359.
52. Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, et al. (2003) Expression of antisense upar and antisense upa from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22: 5967-5975.